Results 121 to 130 of about 180,059 (262)

AMPKγ2 Regulates Cardiac Hypertrophy and Arrhythmias via Interacting With Myosin. [PDF]

Circ Res
Ge Q, Saha K, Burch ML, Battista WH, Kc A, Homilius M, Victorio RA, Quan D, Huang HL, Hazel JM, Williams A, Pan E, Chinthalapudi K, Heissler SM, MacRae CA, Zhu W.   +15 more
europepmc   +1 more source

The Endothelial CXCR Family in Vascular Health and Disease

iNew Medicine, EarlyView.
ABSTRACT Endothelial cells (ECs) form the dynamic interface between blood and tissue, serving as key regulators of vascular homeostasis, inflammation, and repair. Among the molecular systems governing endothelial behavior, the C‐X‐C motif chemokine receptor (CXCR) family—originally characterized in immunology for its roles in leukocyte trafficking and ...
Zhiming Wu, Yandi Wu, Suowen Xu, Yu Huang, Li Wang   +4 more
wiley   +1 more source

USP11 alleviates pathological cardiac hypertrophy via stabilizing SIRT6. [PDF]

Cell Mol Life Sci
Wang X, Zong W, Zhou D, Ji X, An X, Liu Z, Kong L, Wang Y, Fang Y, Gao L, Li Y, Zheng Z, Liu G, Fan S.   +13 more
europepmc   +1 more source

Traditional Chinese Medicine and Natural Products Targeting Right Ventricular Dysfunction in Pulmonary Arterial Hypertension: Toward Precision Cardiometabolic Therapy

iNew Medicine, EarlyView.
Natural products and traditional Chinese medicine target metabolic pathways underlying right ventricular dysfunction in pulmonary arterial hypertension. Integrating multi‐omics, artificial intelligence, and systems biology may enable precision cardiometabolic therapies to restore right ventricular metabolism and improve clinical outcomes.
Yihao Wu, Zhehui Tang, Hongwei Yao
wiley   +1 more source

Cardiomyocyte fusion contributes to cardiac hypertrophy in adult hearts. [PDF]

Mol Med
Colliva A, Di Mauro G, Vodret S, Vuerich R, Bongiovanni W, Ciucci G, Fernetti C, Zacchigna S.   +7 more
europepmc   +1 more source

Genetic Biomarkers in the Risk Assessment of Sudden Cardiac Events: A Personalized Approach

iNew Medicine, EarlyView.
Genetic insights into the risk assessment of sudden cardiac events. ABSTRACT Sudden cardiac events are the leading cause of death worldwide. Conventional risk stratification methods, which largely depend on clinical history, imaging, and electrocardiography, are usually inadequate for identifying high‐risk individuals, especially those without visible ...
Shrikant Verma, Sushma Verma, Mohammad Abbas, Tabrez Faruqui, Bashir Ahmad Mir, Farzana Mahdi   +5 more
wiley   +1 more source

Targeting of Pentraxin 3 Alleviated Cardiac Hypertrophy in Mice Induced by Angiotensin II. [PDF]

Clin Exp Pharmacol Physiol
Tan Q, Gong X, Wu T, Li C, Liu K, Hou D.
europepmc   +1 more source

ECG in epilepsy – Insights on preemptive sudden death detection

Epilepsia, EarlyView.
Guilherme L. Fialho, Katia Lin
wiley   +1 more source

S100A9 promotes pulmonary arterial hypertension by regulating mitochondria–endoplasmic reticulum interaction‐mediated inflammatory injury of endothelial cells

Interdisciplinary Medicine, EarlyView.
Macrophage‐derived S100 calcium‐binding protein A9 (S100A9) promotes the pathological progression of pulmonary arterial hypertension (PAH). S100A9 upregulates the interaction between signal‐transducing adaptor protein 2 and leucine‐rich repeat kinase 2, thereby regulating mitochondria–endoplasmic reticulum (ER) contact.
Chen Gong, Long Chen, Yiting Zhao, Xiaohe Wang, Qiang Yuan, Xiaofeng Fang, Liuyi Li, Yinbo Xu, Shumei Jiang, Guangwen Xu, Ke Meng, Delong Wang, Kangli Cao, Jianlong Sheng, Liling Guo, Shichun Shen   +15 more
wiley   +1 more source

Synthetic Fructoborate Administration: Effects on Cardiac Remodeling and Extracardiac Responses in Isoproterenol-Induced Cardiac Hypertrophy. [PDF]

Pharmaceuticals (Basel)
Ortega-Camarillo C, Díaz-Rosas G, Muñiz-Reyes B, Nieto-Lara PL, Cordova-Chavez RI, Bită A, Soriano-Ursúa MA, Saucedo R, Ávalos-Rodríguez A, Morales-Serna JA, Chávez-García R, Contreras-Ramos A.   +11 more
europepmc   +1 more source